Keyword → ABT

U.S. Economy Entered 2026 at Weakest Pace Since Pandemic as Q4 GDP Revised Down to 0.7%, Raising Stagflation Fears

The U.S. Bureau of Economic Analysis revised Q4 2025 GDP growth sharply lower to a 0.7% annualized rate — half the government's initial estimate and well below economists' 1.4% forecast — painting a troubling portrait of an economy that was already weakening before the Iran war erupted and sent oil prices soaring. The data, combined with a January job market that shed 92,000 positions and lingering above-3% inflation, has amplified stagflation fears ahead of a critical Federal Reserve meeting.

Medtronic Posts Strongest Revenue Growth in Ten Quarters, Reiterates Full-Year Outlook

Medtronic reported third-quarter fiscal 2026 revenue of $9.02 billion, an 8.7% year-over-year increase representing the company's highest enterprise revenue growth in ten quarters, beating analyst estimates of $8.89 billion. Non-GAAP diluted EPS of $1.36 beat consensus by three cents, and the medical device giant reiterated full-year organic revenue growth guidance of approximately 5.5% despite a projected $185 million tariff headwind.

OPKO Health Schedules Q4 Earnings Report, Shares React to Upcoming Guidance

OPKO Health announced plans to release its fourth-quarter and full-year 2025 financial results later this month, expected to include commentary on future revenue and profitability. The upcoming earnings call could influence sentiment among healthcare and biotech investors amid broader market volatility.